[66676058]
This is a pt that received a deceased donor transplant on (b)(6) 2016 and had a fungal infection that required explant of the transplanted organ in (b)(6) 2016. Our center recently received notification from unos regarding a contaminated sps solution that applies to this case. This is the notification received: this is an update to an epi-x posted on (b)(6) 2017, which reported potential bacterial contamination in sps-1 lots pbr-0074-337, pbr-0060-386, pbr-0074-330, and pbr-0060-392. Fda's investigation of potential contamination of several lots of sps-1, manufactured by organ recovery systems (ors) is ongoing. We recommend that organ procurement organizations (opo) and transplant facilities should consider transitioning to alternate, fda-cleared organ preservation fluid products from other mfrs. " please take the following actions to report adverse events occurring on or after (b)(6) 2016, in pts who received organs or tissues from organ recovery procedures using sps-1 from any manufacturing lot file a report with fda's medwatch safety info and adverse event reporting. Therapy start date: (b)(6) 2016. Therapy end date: (b)(6) 2016.
Patient Sequence No: 1, Text Type: D, B5